Journal of hepatology · 1 Sept 2026 · Letter

Extended longitudinal validation of serum procalcitonin as a biomarker for fibrolamellar hepatocellular carcinoma.

Kocheise, Waldmann + more

1 cites

Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's.

The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.

Read the brief in JClub →

Artificial intelligence and personalised medicine in liver cancer.
Journal of hepatology · 1 Oct 2026 · Review
AI-driven multimodal models improve prediction of recurrence and survival in liver cancer, surpassing single-modality approaches in accuracy.
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42684194
Open in JClub
Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCC.
Gut · 6 Aug 2026 · Journal Article
Read the brief in JClub
- Open access
- 3 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42562419
Open in JClub
Clonal diversity underpins distinct modes of recurrence in hepatocellular carcinoma: the PLANet cohort study.
Gut · 21 July 2026 · Journal Article
Read the brief in JClub
- 3 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42481381
Open in JClub

Journals this month

All journals →

Moving areas, week to 3 Oct 2026

All research areas →

Read